AST (aspartate aminotransferase) and ALT (alanine aminotransferase) are enzymes produced primarily in the liver; normal levels typically fall between 7-56 units per liter for AST and 7-55 units per liter for ALT, though reference ranges vary slightly by lab.
These enzymes leak into the bloodstream when liver cells are damaged. Measuring AST and ALT is standard in liver function panels to detect injury, inflammation, or disease. Levels above the upper limit of normal suggest hepatocellular stress. The American Association for the Study of Liver Diseases (AASLD) notes that persistent elevation beyond twice the upper limit of normal warrants further evaluation.
Most people have no symptoms when AST and ALT are mildly elevated. Abnormal results often appear during routine blood work. A single elevated value doesn't confirm liver disease-repeat testing and clinical context are essential. For example, a patient with a history of heavy alcohol use may show AST > ALT, while fatty liver disease often shows ALT > AST.
ALT is predominantly found in liver cells. When liver tissue is injured-by toxins, viruses, or fat accumulation-ALT leaks into the blood. Because ALT is highly specific to the liver, its rise strongly suggests hepatic origin. AST is less specific; it's also present in heart muscle, skeletal muscle, kidneys, and red blood cells.
When muscle trauma occurs, such as after intense exercise or a crush injury, AST can rise independently of liver issues. This explains why athletes sometimes show transient AST elevations without liver problems. ALT remains stable in those cases.
Both enzymes are released during cell death. Their presence in serum reflects ongoing cellular turnover. The ratio of AST to ALT (AST/ALT ratio) helps distinguish causes: a ratio above 1 suggests alcoholic liver disease, while a ratio below 1 points toward non-alcoholic fatty liver disease (NAFLD).
Reference ranges differ by laboratory due to assay methods. Most labs define normal as:
| Test | Normal Range (units/L) | Source |
|---|---|---|
| AST | 7-56 | Clinical Laboratory Standards Institute (CLSI) |
| ALT | 7-55 | CLSI |
Values above 40 U/L are considered elevated. Mild elevations (up to 2× upper limit) may result from medications, obesity, or recent strenuous activity. Moderate increases (2-5×) suggest active liver injury. Severe elevations (>5×) often indicate acute hepatitis or drug toxicity.
A common misconception is that high ALT always means serious illness. In reality, mild ALT elevations occur in up to 15% of adults without identifiable cause. The National Institutes of Health (NIH) reports that many individuals with ALT levels 60-100 U/L have no structural liver disease on imaging or biopsy.
The most frequent causes include non-alcoholic fatty liver disease (NAFLD), alcohol-related liver disease, viral hepatitis (especially B and C), and medication-induced injury. Statins, acetaminophen, and certain antibiotics are known to affect liver enzymes.
For example, a 45-year-old woman with a BMI of 32 presents with ALT 85 U/L and AST 62 U/L. She takes simvastatin daily. Her ultrasound shows fatty infiltration. After stopping the statin and losing 10 pounds, her enzymes normalize within six weeks. This illustrates how lifestyle and drugs contribute to enzyme changes.
Another case: a man with chronic alcohol use has AST 120 U/L and ALT 60 U/L. His AST/ALT ratio is 2:1, consistent with alcoholic liver disease. He improves after cessation and nutritional support.
Many assume that AST and ALT reflect liver function. They do not. These tests measure hepatocyte damage-not synthetic capacity, detoxification, or bile flow. A patient can have normal AST and ALT but still have cirrhosis or portal hypertension.
Also, the term "liver panel" is misleading. AST and ALT are only two components of a full liver assessment. Other markers-such as alkaline phosphatase (ALP), bilirubin, and albumin-are needed to evaluate cholestasis, synthetic function, and disease stage.
One non-obvious fact: AST can be elevated in hemolytic anemia due to red blood cell breakdown. Hemolysis releases intracellular enzymes, including AST. This leads to false-positive interpretation if not considered. A 2021 study in *Hepatology* found that up to 8% of patients with isolated AST elevation had undiagnosed hemolysis.
AST and ALT are included in routine metabolic panels. They're also checked when evaluating fatigue, jaundice, or abnormal liver imaging. Repeat testing after 4-6 weeks is recommended if initial values are mildly elevated and no clear cause is identified.
If both AST and ALT are elevated, consider underlying causes: NAFLD, viral hepatitis, autoimmune hepatitis, or medication side effects. A detailed history-including alcohol intake, supplements, herbal products, and prescription drugs-is critical.
For instance, a 50-year-old man with AST 110 U/L and ALT 130 U/L reports taking green tea extract and turmeric capsules. He stops them, and levels drop to 45 and 50 U/L within eight weeks. This highlights the role of dietary supplements in liver enzyme disruption.
Abnormal results don't always require intervention. Mild elevations without symptoms or risk factors may be monitored. However, sustained elevations above 2× upper limit warrant referral to a hepatologist.
AST and ALT are important tools, but they are not standalone diagnostics. Their interpretation requires integration with clinical findings, imaging, and additional labs. Normal values do not rule out liver disease; abnormal values don't confirm it without context.
Knowing what is normal for AST and ALT helps avoid unnecessary anxiety. But understanding their limitations prevents misdiagnosis. Always interpret results in the full clinical picture.